Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Enact Holdings (ACT) EBT (2020 - 2025)

Enact Holdings has reported EBT over the past 6 years, most recently at $223.1 million for Q4 2025.

  • Quarterly results put EBT at $223.1 million for Q4 2025, up 7.33% from a year ago — trailing twelve months through Dec 2025 was $858.8 million (down 2.19% YoY), and the annual figure for FY2025 was $858.8 million, down 2.19%.
  • EBT for Q4 2025 was $223.1 million at Enact Holdings, up from $209.8 million in the prior quarter.
  • Over the last five years, EBT for ACT hit a ceiling of $260.9 million in Q2 2022 and a floor of $159.0 million in Q1 2021.
  • Median EBT over the past 5 years was $210.7 million (2022), compared with a mean of $209.1 million.
  • Biggest five-year swings in EBT: surged 69.9% in 2021 and later fell 17.92% in 2023.
  • Enact Holdings' EBT stood at $194.9 million in 2021, then dropped by 6.2% to $182.8 million in 2022, then rose by 9.28% to $199.7 million in 2023, then increased by 4.06% to $207.9 million in 2024, then rose by 7.33% to $223.1 million in 2025.
  • The last three reported values for EBT were $223.1 million (Q4 2025), $209.8 million (Q3 2025), and $214.5 million (Q2 2025) per Business Quant data.